Aug 4, 2024, 09:29
The FDA Oncology has approved the first T cell receptor gene therapy for adults with metastatic synovial sarcoma – SITC
Society for Immunotherapy of Cancer (SITC) shared on X:
“The FDA Oncology has approved the first T cell receptor gene therapy for adults with metastatic synovial sarcoma. This cutting-edge treatment is a significant advancement in cancer treatment. Learn more.”
Source: SITC/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 11:28
Feb 22, 2025, 11:22
Feb 22, 2025, 11:15
Feb 22, 2025, 11:02
Feb 22, 2025, 10:47
Feb 22, 2025, 05:18